Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,955 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07231419RecruitingPhase 3
Study of suzetrigine for diabetic nerve pain
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
Birmingham, AlabamaAges 18–80 - NCT07388264Recruiting
Probiotic for bloating and gut health
This study tests a probiotic (a good bacteria) called Weizmannia coagulans to see if it helps reduce bloating and improves gut health. Researchers will check how your digestion changes by looking at your stool and gut bacteria.
Saint Charles, MissouriAges 18–50 - NCT07223229RecruitingPhase 2
Testing EI-001 for vitiligo that hasn't improved with other treatments
This study tests a new drug called EI-001 for people with non-segmental vitiligo (a type where white patches appear on both sides of the body). It is for those whose vitiligo has not gotten better with standard treatments like creams or light therapy, or who cannot use those treatments.
Huntington Beach, CaliforniaAges 18–65 - NCT07219511RecruitingPhase 1
Safety study of VS-041 for heart failure with preserved pumping strength
This trial tests an investigational drug called VS-041 to see if it's safe and helps people with a type of heart failure where the heart pumps well but doesn't relax properly (HFpEF). It may be an option if you are 50 or older and have stable heart failure symptoms.
Little Rock, ArkansasAges 50 years+ - NCT06531863RecruitingEarly Phase 1
Curcumin and green tea supplement for mood improvement
This study tests whether taking curcumin (found in turmeric) and EGCG (found in green tea) can improve mood and increase a brain protein called BDNF, which may help with depression. It is for adults ages 18 to 50 with mild to moderate depression symptoms.
Auburn, AlabamaAges 18–50 - NCT06569056RecruitingPhase 3
HRS-8427 for complicated urinary tract infections
This trial tests a new antibiotic, HRS-8427, for people with complicated urinary tract infections (UTIs) or kidney infections. If you qualify, you would receive the study drug through an IV while in the hospital.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06446869Recruiting
Probiotic for menopause symptoms
This study tests whether a probiotic supplement can help reduce hot flashes and other menopause symptoms. It is for women who are in early menopause and have frequent hot flashes.
Glasgow, GlasgowAges 42–60 - NCT07267559RecruitingPhase 4
Daridorexant and emotion brain testing study
This study tests a medication called daridorexant, which affects the brain's sleep-wake system, to see how it influences emotions and thinking. You will take one dose and complete computer tasks that measure how you process emotional information.
OxfordAges 18–40 - NCT07209306Recruiting
Psychological help for migrants in Italy: The ADVANCE trial
This trial tests two WHO-designed psychological programs (called SH+ and DWM) to help migrants in Italy cope with stress, anxiety, and depression. You will be randomly assigned to one of the programs to see if they improve your mental health and well-being.
Verona, ItalyAges 18 years+ - NCT07209501Enrolling by invitation
Aromatherapy for stem cell transplant patients
This trial tests if inhaling essential oils can help patients who are having a stem cell transplant after high-dose chemotherapy. It aims to see if this is a feasible and acceptable way to feel better during treatment.
SingaporeAges 21–99 - NCT07208279Recruiting
Cognitive Vitality Study: Can Axolt help memory?
This clinical trial is testing whether a special dietary supplement called Axolt can help keep your memory and thinking sharp as you get older. It is for healthy adults 55 and older who live independently and have no major memory problems.
West Palm Beach, FloridaAges 55 years+ - NCT07207434RecruitingPhase 2
Probiotic supplement for pregnant women to improve gut health
This trial tests whether taking a probiotic during pregnancy can improve gut health in women living in areas where gut infections are common. It may help reduce harmful bacteria and related health problems for both you and your baby.
Matiari, SindhAges 18–49 - NCT07204249RecruitingPhase 2
Testing a diabetes drug to help stop meth use
This study tests whether a medication called 'Glutide' (a GLP-1 agonist, similar to drugs used for diabetes) can help people who want to stop or cut down on methamphetamine. It's for those with moderate to severe meth use disorder who have used meth on at least 15 of the past 30 days.
San Francisco, CaliforniaAges 18–65 - NCT07254715RecruitingPhase 4
Itopride for stomach issues from semaglutide in diabetic women
This trial tests if itopride can help with stomach problems caused by semaglutide in diabetic women having a hysterectomy. It aims to see if this combination can improve symptoms like slow stomach emptying.
Cairo, Cairo GovernorateAges 40–60 - NCT06859957RecruitingPhase 3
Melatonin for chronic low back pain
This trial tests if melatonin can help reduce chronic low back pain. If you have had low back pain for at least 3 months that limits your daily activities, this study might be for you.
RotterdamAges 18–65 - NCT06843538RecruitingPhase 3
Tamsulosin for Easier Urination After Pelvic Floor Surgery
This trial tests whether the drug tamsulosin (a medication that relaxes bladder muscles) helps you urinate more easily right after same-day surgery for pelvic organ prolapse or incontinence. It aims to reduce the need for a catheter after surgery.
Cincinnati, OhioAges 18 years+ - NCT06798636RecruitingEarly Phase 1
Psilocybin and mental imagery for young people who self-harm
This study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) combined with a mental imagery therapy can help reduce self-harm thoughts and behaviors in people ages 16–25. You would receive the drug in a safe clinic setting and complete several therapy sessions and questionnaires over a few weeks.
LondonAges 16–25 - NCT07202481Recruiting
Fiber supplements for constipation in women
This trial tests if two types of fiber—one from chicory and one from a plant husk—can help women with constipation move food through their intestines faster. It aims to find a gentle, non-drug option that might work better than what you eat now.
Belo Horizonte, Minas GeraisAges 18–59 - NCT05560477RecruitingPhase 1/Phase 2
Study drug to help meniscus tears heal after knee injury
This early-phase study tests whether AM3101 can improve healing of a meniscus tear in the knee. Participants must meet age, scan, and health-lab requirements, and they will be closely followed during recovery to check safety and benefit.
Cincinnati, OhioAges 18–40 - NCT05719441RecruitingPhase 2
Antibodies plus early HIV treatment to try for HIV remission
This study tests whether giving special HIV-fighting antibodies along with starting standard HIV medicine soon after infection can help you reach “HIV remission.” It may reduce or delay the return of detectable virus, but you must be willing to follow close monitoring and specific study steps.
Birmingham, AlabamaAges 18–70 - NCT06091085RecruitingPhase 1/Phase 2
Acetazolamide for sleep apnea in untreated patients
This study tests a medicine called acetazolamide to see if it can improve how your brain controls breathing during sleep apnea. If you have sleep apnea and are not using treatment, you might be able to join.
Boston, MassachusettsAges 21–80 - NCT06933381Recruiting
Cold spray for pain during Nexplanon insertion
This study tests whether a numbing cold spray (vapocoolant) can reduce pain during Nexplanon implant insertion. If you are getting a Nexplanon placed in your arm, you may be able to join.
Honolulu, HawaiiAges 14 years+ - NCT07198139RecruitingPhase 1/Phase 2
Testing a new norovirus treatment in healthy adults
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
Decatur, GeorgiaAges 18–49 - NCT06803823RecruitingPhase 2
Testing a new drug for agitation in Alzheimer's
This study tests an experimental drug, ONO-2020, to see if it can help reduce agitation in people with Alzheimer's disease. Agitation can include restlessness, pacing, or verbal outbursts, and this trial aims to find a new treatment option.
AichiAges 55–90
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,955 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.